Attendo
103.80 SEK
+0.97 %
Less than 1K followers
ATT
NASDAQ Stockholm
Health Care Providers
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Attendo
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4,875.0 | 4,878.0 | 18,980.0 | 4,742.0 | 4,684.0 | 4,769.0 | 4,796.0 | 18,991.0 |
| EBITDA | 1,029.0 | 868.0 | 3,435.0 | 866.0 | 832.0 | 1,129.0 | 995.0 | 3,822.0 |
| EBIT | 510.0 | 362.0 | 1,425.0 | 356.0 | 324.0 | 623.0 | 515.0 | 1,818.0 |
| EBIT-% | 10.5 % | 7.4 % | 7.5 % | 7.5 % | 6.9 % | 13.1 % | 10.7 % | 9.6 % |
| Profit before taxes | 301.0 | 148.0 | 584.0 | 167.0 | 112.0 | 420.0 | 324.0 | 1,023.0 |
| Net income | 235.0 | 108.0 | 450.0 | 132.0 | 88.0 | 333.0 | 260.0 | 813.0 |